Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-253002.78%
operating margin TTM
-269216.67%
revenue TTM
643.32 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -3.60 |
| peg ratio | -0.11 |
| price to book ratio | 1.15 |
| price to sales ratio | 6,459.94 |
| enterprise value multiple | -3.15 |
| price fair value | 1.15 |
profitability ratios | |
|---|---|
| gross profit margin | -41519.44% |
| operating profit margin | -269216.67% |
| pretax profit margin | -253002.78% |
| net profit margin | -253002.78% |
| return on assets | -27.14% |
| return on equity | -42.57% |
| return on capital employed | -29.88% |
liquidity ratios | |
|---|---|
| current ratio | 29.56 |
| quick ratio | 29.56 |
| cash ratio | 8.62 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 16,881.25 |
| days of payables outstanding | 37.27 |
| cash conversion cycle | 16,843.98 |
| receivables turnover | 0.02 |
| payables turnover | 9.79 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.11 |
| debt equity ratio | 0.13 |
| long term debt to capitalization | 0.11 |
| total debt to capitalization | 0.11 |
| interest coverage | -35.86 |
| cash flow to debt ratio | -2.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.58 |
| cash per share | 2.66 |
| operating cash flow per share | -0.58 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.01 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2,247.97 |
Frequently Asked Questions
When was the last time Altimmune, Inc. (NASDAQ:ALT) reported earnings?
Altimmune, Inc. (ALT) published its most recent earnings results on 13-05-2026.
What is Altimmune, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Altimmune, Inc. (NASDAQ:ALT)'s trailing twelve months ROE is -42.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Altimmune, Inc. (ALT) currently has a ROA of -27.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ALT's net profit margin stand at?
ALT reported a profit margin of -253002.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ALT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 29.56 in the most recent quarter. The quick ratio stood at 29.56, with a Debt/Eq ratio of 0.13.